Veracyte, Inc. (VCYT)

NASDAQ

$45.70

$+1.41

(+3.18%)

Regular Market

Veracyte, Inc. (VCYT) Live Price Chart

Last updated: ⁦2026-10-02 19:37:40⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

Veracyte, Inc. (VCYT) operates in the SERVICES-MEDICAL LABORATORIES sector and is listed on NASDAQ. The stock is currently priced at $45.70, with a market capitalization of $3.70B and a P/E ratio of 31.03. Over the past 52 weeks, its price has ranged from $29.46 to $60.91. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$3.70B
Open	$44.94
Day's High	$86.03
Day's Low	$4.21
Previous Close	$44.19
Volume	504.93K
Average Volume	1.34M
P/E Ratio	31.03
52-Week High	$60.91
52-Week Low	$29.46
Dividend Yield	--
Earnings Date	--

Veracyte, Inc. (VCYT) Stock Price Today

Veracyte, Inc. (VCYT) is currently trading at $45.70 as of 2026-10-02 19:35:00, up 3.42% ($1.51) from the previous close of $44.19

During today's regular trading session, VCYT has traded between $4.21 and $86.03, with a trading volume of 504.93K shares. The current price is near the middle of today's range.

Veracyte, Inc. (VCYT) 7-Day Stock Price Change

Over the past seven days, Veracyte, Inc. (VCYT) moved from $43.82 to $45.70, representing a gain of 4.29% ($1.88).

The stock traded between $42.25 and $49.00 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.

The average daily volume was 1.72 million shares, up versus the previous seven-day period, indicating higher trading activity.

VCYT 52-Week Price Position

Position in Range: 51.6%

52W Low$29.46

52W High$60.91

VCYT is currently trading at $45.70, placing it 51.6% of the way from its 52-week low of $29.46 to its 52-week high of $60.91. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Veracyte, Inc. (VCYT)?

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).

Veracyte, Inc. Information

Industry	SERVICES-MEDICAL LABORATORIES
Employees	755
Exchange	NASDAQ
Company Website	https://www.veracyte.com

How to Buy Veracyte, Inc. (VCYT) Stock on MEXC

Eligible investors can buy real shares of Veracyte, Inc. (VCYT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for VCYT and Place Your Order

Open the RealStocks trading page and search for VCYT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Veracyte, Inc. (VCYT) stock price today?

Veracyte, Inc. (VCYT) is currently trading at $ 45.70, up 3.42% ($1.51) from the previous close of $ 44.19. Intraday prices update in real time during regular trading hours.

2.Is VCYT stock going up or down today?

As of 2026-10-02 19:35:00, VCYT is trading at $ 45.70, up 3.42% ($1.51) from its previous close of $ 44.19. The stock has traded between $ 4.21 and $ 86.03 during today’s regular session. Past price movements do not guarantee future results.

3.What is VCYT pre-market price?

As of 2026-10-02 19:35:00, VCYT is trading at $ 44.83 in pre-market trading, up 1.45% ($0.64) from the previous close of $ 44.19. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is VCYT after-hours price?

As of 2026-10-02 19:35:00, VCYT is trading at $ 44.55 in after-hours trading, up 0.82% ($0.36) from the regular-session close of $ 44.19. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is VCYT stock trading now?

VCYT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does VCYT sit relative to its 52-week high and low?

Over the past 52 weeks, VCYT has traded between a low of $ 29.46 and a high of $ 60.91. At $ 45.70, the stock is positioned 51.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Veracyte, Inc. in?

Veracyte, Inc. (VCYT) operates in the SERVICES-MEDICAL LABORATORIES sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Veracyte, Inc.'s market capitalization and where is it listed?

Veracyte, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 3.70B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is VCYT valued in terms of P/E ratio and EPS?

VCYT trades at a P/E ratio of 31.03, based on trailing-twelve-month EPS of $ 1.42. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Veracyte, Inc. pay a dividend?

Veracyte, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.